Nifedipine Tablet
Short Description
Product Composition & Structural FormatsWe manufacture Nifedipine across the complete clinical dosage spectrum, utilizing distinct release matrices calibrated for immediate stabilization or sustained, once-daily therapeutic coverage.
|
Full Description
Nifedipine TabletNifedipine Modified & Extended-Release Tablets (10 mg / 20 mg / 30 mg / 60 mg)Healthy Life Pharma Private Limited, alongside our global marketing and export division Healthy Inc, is a premier Indian manufacturer, CDMO partner, and wholesale exporter of advanced cardiovascular, anti-hypertensive, and maternal-fetal therapeutics. We manufacture a comprehensive, internationally standardized range of Nifedipine Tablets (10 mg / 20 mg / 30 mg / 60 mg) within our WHO–GMP certified, high-precision solid dosage manufacturing installations. This foundational "Dihydropyridine Calcium Channel Blocker" serves as a high-volume strategic export to cardiology centers, institutional state hospital networks, public health ministry tenders, and international B2B wholesale marketplaces across Africa, the CIS region, LATAM, and Southeast Asia. Product OverviewThis formulation operates as a "Selective Smooth Muscle Calcium Channel Antagonist." It ensures patient safety by chemically blocking calcium influx into vascular tissue, physically relaxing peripheral and coronary arterial walls to reduce systemic blood pressure and prevent ischemic chest pain.
Product Composition & Structural FormatsWe manufacture Nifedipine across the complete clinical dosage spectrum, utilizing distinct release matrices calibrated for immediate stabilization or sustained, once-daily therapeutic coverage.
Technical & Logistics Specifications
Photo-Shielding Engineering & Extended-Release Kinetics
Primary Indications
Usage Instructions
Safety Warning: POTENT CARDIOVASCULAR MODIFIER. For Professional Medical Supervision Only. Reflex Tachycardia Risk: Immediate-release forms may cause rapid peripheral vasodilation followed by sympathetic Reflex Tachycardia; manage acute titration windows carefully. Peripheral Edema Note: Vasodilation can physically cause localized fluid shifts in the lower extremities (ankle swelling); evaluate parameters chemically if fluid retention persists. Contraindication: Do not use in cases of cardiogenic shock, severe aortic stenosis, within 4 weeks of a myocardial infarction, or known hypersensitivity to dihydropyridine derivatives. Global CDMO Services & Wholesale Supply ChainHealthy Life Pharma Private Limited and Healthy Inc provide complete, internationally validated Third-Party Contract Manufacturing (CDMO Services) and high-volume private-label production for the entire Nifedipine dosage spectrum. Whether you are fulfilling a high-volume procurement contract for a National Health Ministry Tender, stocking state hospital infrastructure in the CIS, or injecting inventory into a digital B2B Pharmaceutical Marketplace across Southeast Asia or LATAM, we deliver all required documentation (WHO-GMP Certificate, COPP, COA, Stability Testing Matrix Sheets, and Complete CTD Format Dossier sets) for rapid entry registration. Commercial & Bulk Procurement Inquiries:
|
Request a Quote
Contact our export team for product availability, packaging and documentation.
For professional procurement information only. Consult a qualified healthcare professional before using any medicine.
Rate this Product
Frequently Asked Questions
How can I request a quote for this product?
Use the enquiry form on this page or contact our export team by email or WhatsApp.
How can I confirm packaging and documentation?
Contact our export team to confirm product availability, packaging and documentation.

Amlodipine & Enalapril Maleate Tablets
Amlodipine Besylate & Losartan Potassium Tablets
Amlodipine Tablet
Amlodipine With Lisinopril Dehydrate Tablets
Atenolol & Chlorthalidone Tablets